GLOBAL AGE RELATED MACULAR DEGENERATION TREATMENT MARKET 2022 BY COMPANY, REGIONS, TYPE AND APPLICATION, FORECAST TO 2028

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Age Related Macular Degeneration Treatment
1.2 Classification of Age Related Macular Degeneration Treatment by Type
1.2.1 Overview: Global Age Related Macular Degeneration Treatment Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Age Related Macular Degeneration Treatment Revenue Market Share by Type in 2021
1.2.3 Lucentis
1.2.4 Eylea
1.2.5 Avastin
1.2.6 Other
1.3 Global Age Related Macular Degeneration Treatment Market by Application
1.3.1 Overview: Global Age Related Macular Degeneration Treatment Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Age Related Macular Degeneration Treatment Market Size & Forecast
1.5 Global Age Related Macular Degeneration Treatment Market Size and Forecast by Region
1.5.1 Global Age Related Macular Degeneration Treatment Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Age Related Macular Degeneration Treatment Market Size by Region, (2017-2022)
1.5.3 North America Age Related Macular Degeneration Treatment Market Size and Prospect (2017-2028)
1.5.4 Europe Age Related Macular Degeneration Treatment Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Age Related Macular Degeneration Treatment Market Size and Prospect (2017-2028)
1.5.6 South America Age Related Macular Degeneration Treatment Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Age Related Macular Degeneration Treatment Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Age Related Macular Degeneration Treatment Market Drivers
1.6.2 Age Related Macular Degeneration Treatment Market Restraints
1.6.3 Age Related Macular Degeneration Treatment Trends Analysis
2 Company Profiles
2.1 Regeneron Pharmaceuticals
2.1.1 Regeneron Pharmaceuticals Details
2.1.2 Regeneron Pharmaceuticals Major Business
2.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Product and Solutions
2.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Regeneron Pharmaceuticals Recent Developments and Future Plans
2.2 Bayer HealthCare
2.2.1 Bayer HealthCare Details
2.2.2 Bayer HealthCare Major Business
2.2.3 Bayer HealthCare Age Related Macular Degeneration Treatment Product and Solutions
2.2.4 Bayer HealthCare Age Related Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Bayer HealthCare Recent Developments and Future Plans
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Age Related Macular Degeneration Treatment Product and Solutions
2.3.4 Novartis Age Related Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Novartis Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Age Related Macular Degeneration Treatment Product and Solutions
2.4.4 Roche Age Related Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Roche Recent Developments and Future Plans
2.5 Kanghong Pharma
2.5.1 Kanghong Pharma Details
2.5.2 Kanghong Pharma Major Business
2.5.3 Kanghong Pharma Age Related Macular Degeneration Treatment Product and Solutions
2.5.4 Kanghong Pharma Age Related Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Kanghong Pharma Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Age Related Macular Degeneration Treatment Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Age Related Macular Degeneration Treatment Players Market Share in 2021
3.2.2 Top 10 Age Related Macular Degeneration Treatment Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Age Related Macular Degeneration Treatment Players Head Office, Products and Services Provided
3.4 Age Related Macular Degeneration Treatment Mergers & Acquisitions
3.5 Age Related Macular Degeneration Treatment New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Age Related Macular Degeneration Treatment Revenue and Market Share by Type (2017-2022)
4.2 Global Age Related Macular Degeneration Treatment Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Age Related Macular Degeneration Treatment Revenue Market Share by Application (2017-2022)
5.2 Global Age Related Macular Degeneration Treatment Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Age Related Macular Degeneration Treatment Revenue by Type (2017-2028)
6.2 North America Age Related Macular Degeneration Treatment Revenue by Application (2017-2028)
6.3 North America Age Related Macular Degeneration Treatment Market Size by Country
6.3.1 North America Age Related Macular Degeneration Treatment Revenue by Country (2017-2028)
6.3.2 United States Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
6.3.3 Canada Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
6.3.4 Mexico Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Age Related Macular Degeneration Treatment Revenue by Type (2017-2028)
7.2 Europe Age Related Macular Degeneration Treatment Revenue by Application (2017-2028)
7.3 Europe Age Related Macular Degeneration Treatment Market Size by Country
7.3.1 Europe Age Related Macular Degeneration Treatment Revenue by Country (2017-2028)
7.3.2 Germany Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
7.3.3 France Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
7.3.5 Russia Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
7.3.6 Italy Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Age Related Macular Degeneration Treatment Revenue by Type (2017-2028)
8.2 Asia-Pacific Age Related Macular Degeneration Treatment Revenue by Application (2017-2028)
8.3 Asia-Pacific Age Related Macular Degeneration Treatment Market Size by Region
8.3.1 Asia-Pacific Age Related Macular Degeneration Treatment Revenue by Region (2017-2028)
8.3.2 China Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
8.3.3 Japan Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
8.3.4 South Korea Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
8.3.5 India Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
8.3.7 Australia Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Age Related Macular Degeneration Treatment Revenue by Type (2017-2028)
9.2 South America Age Related Macular Degeneration Treatment Revenue by Application (2017-2028)
9.3 South America Age Related Macular Degeneration Treatment Market Size by Country
9.3.1 South America Age Related Macular Degeneration Treatment Revenue by Country (2017-2028)
9.3.2 Brazil Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
9.3.3 Argentina Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Age Related Macular Degeneration Treatment Revenue by Type (2017-2028)
10.2 Middle East & Africa Age Related Macular Degeneration Treatment Revenue by Application (2017-2028)
10.3 Middle East & Africa Age Related Macular Degeneration Treatment Market Size by Country
10.3.1 Middle East & Africa Age Related Macular Degeneration Treatment Revenue by Country (2017-2028)
10.3.2 Turkey Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
10.3.4 UAE Age Related Macular Degeneration Treatment Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Age Related Macular Degeneration Treatment Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Age Related Macular Degeneration Treatment Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Age Related Macular Degeneration Treatment Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Age Related Macular Degeneration Treatment Revenue (USD Million) by Region (2017-2022)
Table 5. Global Age Related Macular Degeneration Treatment Revenue Market Share by Region (2023-2028)
Table 6. Regeneron Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 7. Regeneron Pharmaceuticals Major Business
Table 8. Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Product and Solutions
Table 9. Regeneron Pharmaceuticals Age Related Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Bayer HealthCare Corporate Information, Head Office, and Major Competitors
Table 11. Bayer HealthCare Major Business
Table 12. Bayer HealthCare Age Related Macular Degeneration Treatment Product and Solutions
Table 13. Bayer HealthCare Age Related Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Novartis Corporate Information, Head Office, and Major Competitors
Table 15. Novartis Major Business
Table 16. Novartis Age Related Macular Degeneration Treatment Product and Solutions
Table 17. Novartis Age Related Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Age Related Macular Degeneration Treatment Product and Solutions
Table 21. Roche Age Related Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Kanghong Pharma Corporate Information, Head Office, and Major Competitors
Table 23. Kanghong Pharma Major Business
Table 24. Kanghong Pharma Age Related Macular Degeneration Treatment Product and Solutions
Table 25. Kanghong Pharma Age Related Macular Degeneration Treatment Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Global Age Related Macular Degeneration Treatment Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 27. Global Age Related Macular Degeneration Treatment Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 28. Breakdown of Age Related Macular Degeneration Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Age Related Macular Degeneration Treatment Players Head Office, Products and Services Provided
Table 30. Age Related Macular Degeneration Treatment Mergers & Acquisitions in the Past Five Years
Table 31. Age Related Macular Degeneration Treatment New Entrants and Expansion Plans
Table 32. Global Age Related Macular Degeneration Treatment Revenue (USD Million) by Type (2017-2022)
Table 33. Global Age Related Macular Degeneration Treatment Revenue Share by Type (2017-2022)
Table 34. Global Age Related Macular Degeneration Treatment Revenue Forecast by Type (2023-2028)
Table 35. Global Age Related Macular Degeneration Treatment Revenue by Application (2017-2022)
Table 36. Global Age Related Macular Degeneration Treatment Revenue Forecast by Application (2023-2028)
Table 37. North America Age Related Macular Degeneration Treatment Revenue by Type (2017-2022) & (USD Million)
Table 38. North America Age Related Macular Degeneration Treatment Revenue by Type (2023-2028) & (USD Million)
Table 39. North America Age Related Macular Degeneration Treatment Revenue by Application (2017-2022) & (USD Million)
Table 40. North America Age Related Macular Degeneration Treatment Revenue by Application (2023-2028) & (USD Million)
Table 41. North America Age Related Macular Degeneration Treatment Revenue by Country (2017-2022) & (USD Million)
Table 42. North America Age Related Macular Degeneration Treatment Revenue by Country (2023-2028) & (USD Million)
Table 43. Europe Age Related Macular Degeneration Treatment Revenue by Type (2017-2022) & (USD Million)
Table 44. Europe Age Related Macular Degeneration Treatment Revenue by Type (2023-2028) & (USD Million)
Table 45. Europe Age Related Macular Degeneration Treatment Revenue by Application (2017-2022) & (USD Million)
Table 46. Europe Age Related Macular Degeneration Treatment Revenue by Application (2023-2028) & (USD Million)
Table 47. Europe Age Related Macular Degeneration Treatment Revenue by Country (2017-2022) & (USD Million)
Table 48. Europe Age Related Macular Degeneration Treatment Revenue by Country (2023-2028) & (USD Million)
Table 49. Asia-Pacific Age Related Macular Degeneration Treatment Revenue by Type (2017-2022) & (USD Million)
Table 50. Asia-Pacific Age Related Macular Degeneration Treatment Revenue by Type (2023-2028) & (USD Million)
Table 51. Asia-Pacific Age Related Macular Degeneration Treatment Revenue by Application (2017-2022) & (USD Million)
Table 52. Asia-Pacific Age Related Macular Degeneration Treatment Revenue by Application (2023-2028) & (USD Million)
Table 53. Asia-Pacific Age Related Macular Degeneration Treatment Revenue by Region (2017-2022) & (USD Million)
Table 54. Asia-Pacific Age Related Macular Degeneration Treatment Revenue by Region (2023-2028) & (USD Million)
Table 55. South America Age Related Macular Degeneration Treatment Revenue by Type (2017-2022) & (USD Million)
Table 56. South America Age Related Macular Degeneration Treatment Revenue by Type (2023-2028) & (USD Million)
Table 57. South America Age Related Macular Degeneration Treatment Revenue by Application (2017-2022) & (USD Million)
Table 58. South America Age Related Macular Degeneration Treatment Revenue by Application (2023-2028) & (USD Million)
Table 59. South America Age Related Macular Degeneration Treatment Revenue by Country (2017-2022) & (USD Million)
Table 60. South America Age Related Macular Degeneration Treatment Revenue by Country (2023-2028) & (USD Million)
Table 61. Middle East & Africa Age Related Macular Degeneration Treatment Revenue by Type (2017-2022) & (USD Million)
Table 62. Middle East & Africa Age Related Macular Degeneration Treatment Revenue by Type (2023-2028) & (USD Million)
Table 63. Middle East & Africa Age Related Macular Degeneration Treatment Revenue by Application (2017-2022) & (USD Million)
Table 64. Middle East & Africa Age Related Macular Degeneration Treatment Revenue by Application (2023-2028) & (USD Million)
Table 65. Middle East & Africa Age Related Macular Degeneration Treatment Revenue by Country (2017-2022) & (USD Million)
Table 66. Middle East & Africa Age Related Macular Degeneration Treatment Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Age Related Macular Degeneration Treatment Picture
Figure 2. Global Age Related Macular Degeneration Treatment Revenue Market Share by Type in 2021
Figure 3. Lucentis
Figure 4. Eylea
Figure 5. Avastin
Figure 6. Other
Figure 7. Age Related Macular Degeneration Treatment Revenue Market Share by Application in 2021
Figure 8. Hospital Picture
Figure 9. Clinic Picture
Figure 10. Other Picture
Figure 11. Global Age Related Macular Degeneration Treatment Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 12. Global Age Related Macular Degeneration Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Age Related Macular Degeneration Treatment Revenue Market Share by Region (2017-2028)
Figure 14. Global Age Related Macular Degeneration Treatment Revenue Market Share by Region in 2021
Figure 15. North America Age Related Macular Degeneration Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Europe Age Related Macular Degeneration Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Asia-Pacific Age Related Macular Degeneration Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. South America Age Related Macular Degeneration Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Middle East and Africa Age Related Macular Degeneration Treatment Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. Age Related Macular Degeneration Treatment Market Drivers
Figure 21. Age Related Macular Degeneration Treatment Market Restraints
Figure 22. Age Related Macular Degeneration Treatment Market Trends
Figure 23. Regeneron Pharmaceuticals Recent Developments and Future Plans
Figure 24. Bayer HealthCare Recent Developments and Future Plans
Figure 25. Novartis Recent Developments and Future Plans
Figure 26. Roche Recent Developments and Future Plans
Figure 27. Kanghong Pharma Recent Developments and Future Plans
Figure 28. Global Age Related Macular Degeneration Treatment Revenue Share by Players in 2021
Figure 29. Age Related Macular Degeneration Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 30. Global Top 3 Players Age Related Macular Degeneration Treatment Revenue Market Share in 2021
Figure 31. Global Top 10 Players Age Related Macular Degeneration Treatment Revenue Market Share in 2021
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 33. Global Age Related Macular Degeneration Treatment Revenue Share by Type in 2021
Figure 34. Global Age Related Macular Degeneration Treatment Market Share Forecast by Type (2023-2028)
Figure 35. Global Age Related Macular Degeneration Treatment Revenue Share by Application in 2021
Figure 36. Global Age Related Macular Degeneration Treatment Market Share Forecast by Application (2023-2028)
Figure 37. North America Age Related Macular Degeneration Treatment Sales Market Share by Type (2017-2028)
Figure 38. North America Age Related Macular Degeneration Treatment Sales Market Share by Application (2017-2028)
Figure 39. North America Age Related Macular Degeneration Treatment Revenue Market Share by Country (2017-2028)
Figure 40. United States Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Age Related Macular Degeneration Treatment Sales Market Share by Type (2017-2028)
Figure 44. Europe Age Related Macular Degeneration Treatment Sales Market Share by Application (2017-2028)
Figure 45. Europe Age Related Macular Degeneration Treatment Revenue Market Share by Country (2017-2028)
Figure 46. Germany Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Age Related Macular Degeneration Treatment Sales Market Share by Type (2017-2028)
Figure 52. Asia-Pacific Age Related Macular Degeneration Treatment Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Age Related Macular Degeneration Treatment Revenue Market Share by Region (2017-2028)
Figure 54. China Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Japan Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. South Korea Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. India Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Southeast Asia Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Australia Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. South America Age Related Macular Degeneration Treatment Sales Market Share by Type (2017-2028)
Figure 61. South America Age Related Macular Degeneration Treatment Sales Market Share by Application (2017-2028)
Figure 62. South America Age Related Macular Degeneration Treatment Revenue Market Share by Country (2017-2028)
Figure 63. Brazil Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Argentina Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Middle East and Africa Age Related Macular Degeneration Treatment Sales Market Share by Type (2017-2028)
Figure 66. Middle East and Africa Age Related Macular Degeneration Treatment Sales Market Share by Application (2017-2028)
Figure 67. Middle East and Africa Age Related Macular Degeneration Treatment Revenue Market Share by Country (2017-2028)
Figure 68. Turkey Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Saudi Arabia Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. UAE Age Related Macular Degeneration Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source